康泰生物前三季度净利同比降逾八成

Core Insights - The company reported a revenue of 2.063 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 2.24% [1] - The net profit attributable to shareholders for the same period was 49.1577 million yuan, showing a significant decline of 86% year-on-year [1] - In the third quarter, the company achieved a revenue of 671 million yuan, which is a decrease of 17.74% compared to the same period last year [1] - The net profit for the third quarter was 11.6249 million yuan, reflecting a drastic decline of 93.74% year-on-year [1]